Ardent Health, Inc. (ARDT)

Market Cap	1.35B -37.4%
Revenue (ttm)	6.33B +10.9%
Net Income	205.06M +122.9%
EPS	1.44 +102.5%
Shares Out	143.19M
PE Ratio	6.52
Forward PE	7.97
Dividend	n/a
Ex-Dividend Date	n/a

Volume	294,594
Open	9.49
Previous Close	9.56
Day's Range	9.26 - 9.54
52-Week Range	8.07 - 15.59
Beta	n/a
Analysts	Buy
Price Target	14.20 (+50.9%)
Earnings Date	Mar 4, 2026

About ARDT

Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers, urgent care ce...

• Industry: Medical Care Facilities
• Sector: Healthcare
• IPO Date: Jul 18, 2024
• Employees: 24,900
• Stock Exchange: NYSE
• Ticker Symbol: ARDT
• Website: https://www.ardenthealth.com

Financial Performance

In 2024, Ardent Health's revenue was $5.97 billion, an increase of 10.29% compared to the previous year's $5.41 billion. Earnings were $210.34 million, an increase of 290.22%.

Analyst Summary

According to 11 analysts, the average rating for ARDT stock is "Buy." The 12-month stock price target is $14.2, which is an increase of 50.90% from the latest price.

Price Target

$14.2

(50.90% upside)

Analyst Consensus: Buy